Similar to iRGE, the targeting peptide CLKADKAKC (CK3) contains a potential CendR motif and has been studied for SPECT imaging of breast cancer, but no comparative analysis has been performed for the difference in tumor targeting ability between CK3 and iRGD (Feng et al., 2014). This evidence concerns the gene KRT3 and breast cancer.